ContactTeam
IGES Pharma provides solutions for your market access challenges. We consider our broad experience as a toolbox at your service. Depending on your needs and specifications, tailored solutions are put together from one source, integrating expertise and experts from our subsidiaries in Europe as needed.
Janice Acker
Value & Access Strategy
Dr. Amir Ansaripour
Health Economics & Outcomes Research
Katharina Barton
Value & Access Strategy
Eika Louisa Bergemann
HTA & Value Demonstration
Fabian Berkemeier
Managing Director Pharma & Biotech
Dr. Jolantha Beyerle
HTA & Value Demonstration
Dr. Barbara Bosch
HTA & Value Demonstration
Wiebke Braunschweig
Statistics & Biometrics
Susanne Brückel
HTA & Value Demonstration
Agata Daroszewska
Public Affairs
Dr. Veronika Deák
Value & Access Strategy
Marie Derstroff
Value & Access Strategy
Dr. Katrin Domes-Martin
HTA & Value Demonstration
Alice Elisabeth dos Reis Dias Heller
HTA & Value Demonstration
Saskia Ehrenfried
HTA & Value Demonstration
Undine Euker
HTA & Value Demonstration
Gamze Fackelmann
Health Economics & Outcomes Research
Dr. Norbert Gerbsch
Public Affairs
Melissa Gomez Montero
Health Economics & Outcomes Research
Peter Gray
Statistics & Biometrics
Donald Lorenz Gujer
HTA & Value Demonstration
Prof. Dr. Bertram Häussler
Chairman of the Board of Management Health Services Research
Stefan Hargesheimer
Value & Access Strategy
Carl-Christoph Henkel
Clinical Research
Dr. Jana Heppt
HTA & Value Demonstration
Juna Hertlein
Value & Access Strategy
Dr. Ariane Höer
Pharmaceutical Market Research
Dr. Pascale Holzerny
HTA & Value Demonstration
Bennet Huebbe
Value & Access Strategy
Dr. Mehdi Javanbakht
Director Health Economics & Outcomes Research
Sandra Jessel
Public Affairs
Vasileios Kontogiannis
Health Economics & Outcomes Research
Wioletta Kotowa
Authorized Signatory Pharma & Biotech
Heidi Kulas
Statistics & Biometrics
Dr. Marc Kurepkat
CEO Clinical Research
Julia Isabella Krieger
Value & Access Strategy
Florentine Lang
HTA & Value Demonstration
Hong Anh Le
Value & Access Strategy
Lukas Maag
Pharmaceutical Market Research
Dr. Tilo Mandry
Lead International Liaison Manager
Karina Manz
Value & Access Strategy
Atefeh Mashayekhi
Health Economics & Outcomes Research
Jörg Mathes
HTA & Value Demonstration
Dr. Ann-Katrin Menzner
HTA & Value Demonstration
Tatjana Meyer
HTA & Value Demonstration
Pierre Moïse
Managing Director IGES France Pharma Consulting (IFPC)
Eoin Moloney
Health Economics & Outcomes Research
Santoke Naal
Managing Director IGES UK Pharma Consulting (IUPC)
Rohan Naal
Market Access UK
Corinne Perret
HTA & Value Demonstration
Stefan Reindl
HTA & Value Demonstration
Dr. Stephan Ruckdäschel
Managing Director HealthEcon | CH
Brigitte Roch
Market Access France
Teresa Romaguera
HTA & Value Demonstration
Guido Schiffhorst
Director of Statistics & Biometrics
Evelyn Elisabeth Schlegl-Zanetti
HTA & Value Demonstration
Dr. David Steinl
HTA & Value Demonstration
Stephanie Sussmann
Value & Access Strategy
Thanh Thao Tran
Value & Access Strategy
Dr. Silvia Uecker
Clinical Research
Eveline van Eerd
HTA & Value Demonstration
Lara Luisa Wolff
Value & Access Strategy
Martha Wolfram
Value & Access Strategy
Dr. Elke Ziegler
HTA & Value Demonstration
Johannes Ziemen
HTA & Value Demonstration
Further Team Members
- Nikola Göttler | HTA & Value Demonstration
- Patrick Lambert | Clinical Research
- Dr. Jana Maresch | HTA & Value Demonstration
- Tamsin Markanday | Market Access UK
- Dr. Barbara Obertreis | HTA & Value Demonstration
- Christina Reisinger | HTA & Value Demonstration
- Elena Reith | Value & Access Strategy
- Maciej Rowinski | Statistics & Biometrics
- Zihao Wu | Market Access UK
